Renaissance Technologies’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-401,681
| Closed | -$1.49M | – | 4190 |
|
|
2022
Q2 | $1.49M | Buy |
+401,681
| New | +$1.49M | ﹤0.01% | 2415 |
|
|
2022
Q1 | – | Sell |
-304,900
| Closed | -$1.85M | – | 4239 |
|
|
2021
Q4 | $1.85M | Buy |
304,900
+96,983
| +47% | +$590K | ﹤0.01% | 2201 |
|
|
2021
Q3 | $2.03M | Buy |
+207,917
| New | +$2.03M | ﹤0.01% | 2081 |
|
|
2020
Q3 | – | Sell |
-32,745
| Closed | -$402K | – | 3499 |
|
|
2020
Q2 | $402K | Sell |
32,745
-1,657,218
| -98% | -$20.3M | ﹤0.01% | 2936 |
|
|
2020
Q1 | $4.87M | Buy |
1,689,963
+55,038
| +3% | +$159K | ﹤0.01% | 1577 |
|
|
2019
Q4 | $6.2M | Buy |
1,634,925
+39,200
| +2% | +$149K | ﹤0.01% | 1730 |
|
|
2019
Q3 | $1.95M | Buy |
1,595,725
+83,400
| +6% | +$102K | ﹤0.01% | 2295 |
|
|
2019
Q2 | $1.54M | Buy |
1,512,325
+280,108
| +23% | +$286K | ﹤0.01% | 2478 |
|
|
2019
Q1 | $1.95M | Buy |
1,232,217
+155,000
| +14% | +$245K | ﹤0.01% | 2318 |
|
|
2018
Q4 | $1.25M | Buy |
1,077,217
+376,650
| +54% | +$437K | ﹤0.01% | 2469 |
|
|
2018
Q3 | $2.59M | Buy |
700,567
+180,167
| +35% | +$667K | ﹤0.01% | 2155 |
|
|
2018
Q2 | $1.59M | Buy |
520,400
+218,200
| +72% | +$668K | ﹤0.01% | 2390 |
|
|
2018
Q1 | $1.18M | Buy |
302,200
+69,300
| +30% | +$270K | ﹤0.01% | 2593 |
|
|
2017
Q4 | $1.05M | Buy |
232,900
+43,800
| +23% | +$197K | ﹤0.01% | 2645 |
|
|
2017
Q3 | $1.04M | Buy |
189,100
+99,700
| +112% | +$546K | ﹤0.01% | 2560 |
|
|
2017
Q2 | $679K | Sell |
89,400
-396,700
| -82% | -$3.01M | ﹤0.01% | 2684 |
|
|
2017
Q1 | $1.73M | Buy |
486,100
+461,600
| +1,884% | +$1.64M | ﹤0.01% | 2320 |
|
|
2016
Q4 | $140K | Buy |
+24,500
| New | +$140K | ﹤0.01% | 3057 |
|
|
2016
Q2 | – | Sell |
-16,700
| Closed | -$137K | – | 3408 |
|
|
2016
Q1 | $137K | Buy |
+16,700
| New | +$137K | ﹤0.01% | 3165 |
|